{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-031778","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.113329+00:00","generated_at":"2026-06-01T00:28:35.992944+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"ADMA Biologics amends bylaws to reduce director removal threshold to majority vote and add exclusive forum provisions","bullets":["Reduced director removal with cause threshold from 66 2/3% to a majority of voting holders.","Added exclusive forum provision requiring internal corporate suits be brought in Delaware courts.","Added federal forum selection clause for Securities Act claims unless company consents otherwise."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-031778","json":"https://secwatch.observer/filing/0001140361-24-031778.json","markdown":"https://secwatch.observer/filing/0001140361-24-031778.md","text":"https://secwatch.observer/filing/0001140361-24-031778.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124031778/0001140361-24-031778-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124031778/ef20031848_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:28:35.992944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}